Authors
Latest:
How Voice Recognition Technologies Can Be Used to Accelerate Patient TrialsBecause of the growing rate of voice assistant applications, such as Alexa, healthcare and life sciences organizations are beginning to design a range of scenarios for deploying these voice assistant platforms in the clinical trial setting.
Latest:
The Hidden Costs of Paper-Based Clinical Outcome AssessmentsClinical trials using electronic Clinical Outcome Assessments (eCOA) benefit from compliance rates 300% higher than paper-based studies - but some sponsor shy away from eCOA adoption due to a misconception that paper diaries are cheaper. Read our eBook to understand the frequently neglected cost calculations proving that eCOA is the cost-effective and superior data collection solution for many clinical trials.
Latest:
Operational Challenges for Biosimilar StudiesUsing strategic planning to address hurdles in biosimilar development programs from the outset.
Latest:
Operational Challenges for Biosimilar StudiesUsing strategic planning to address hurdles in biosimilar development programs from the outset.
Latest:
Recruiting Diabetes SubjectsThe disconnect coordinating and connecting interested patients to clinical trials is an ongoing struggle.
Latest:
The 3 Essential Factors Affecting FDA Inspection OutcomeThis article focuses on the 3 essential factors that have a significant impact on the outcome of any inspection or audit. The author applies this primarily to GCP (Good Clinical Practice) inspections, but the principles are universal, being applicable to any government inspection such as the FDA (U.S. Food & Drug Administration) or industry QA (Quality Assurance) audit.
Latest:
eCOA Increases Patient-Site Communication and CandorWorldwide Clinical Trials recently announced the results of a survey that evaluated the perceptions of clinical trial site investigators who use electronic clinical outcome assessment (eCOA) technologies.
Latest:
5 Common Mistakes With Spirometry in Clinical TrialsSolutions to overcoming the most frequent missteps when collecting valuable spirometry data in respiratory studies.
Latest:
5 Common Mistakes With Spirometry in Clinical TrialsSolutions to overcoming the most frequent missteps when collecting valuable spirometry data in respiratory studies.
Latest:
5 Common Mistakes With Spirometry in Clinical TrialsSolutions to overcoming the most frequent missteps when collecting valuable spirometry data in respiratory studies.
Latest:
5 Common Mistakes With Spirometry in Clinical TrialsSolutions to overcoming the most frequent missteps when collecting valuable spirometry data in respiratory studies.
Latest:
Personalized Medicine DevelopmentAs the popularity of personalized medicine grows the role of the CRO continues to evolve.
Latest:
Trial Participants Are Heroes, Let’s Treat Them That WaySteve Rosenberg, CEO of uMotif gives commentary on providing clinical trial patients with the best experience possible.
Latest:
Learning from Failure, Leveraging Biosimulation for Pediatric Drug Development SuccessPediatric trials now feature increased modeling and analytics for safer drug dosing and response.
Latest:
Learning from Failure, Leveraging Biosimulation for Pediatric Drug Development SuccessPediatric trials now feature increased modeling and analytics for safer drug dosing and response.
Latest:
Developing New Clinical Endpoints for Immuno-Oncology StudiesDrug developers are using surrogate endpoints to monitor the effectiveness of immunotherapies, taking into account the differences between immunotherapy and traditional treatments.
Latest:
Improving Patient Engagement through eCOAHow the adoption of electronic clinical outcome assessment in trials can drive increased communication and patient reporting of events.
Latest:
Rare Diseases and the Eye - Envisioning Strategies for SuccessDeveloping therapies and successfully executing clinical trials for rare ophthalmologic disorders present unique challenges, but with these challenges come significant opportunities to employ innovative strategies to drive success. Explore how careful feasibility and novel approaches to patient recruitment can advance the treatment of rare conditions of the eye. Live: Friday, 27 Oct., 2017 | 11 am EDT | 8 am PDT | 1600 BST | 1700 CEST / On Demand available after airing until 27 Oct., 2018. Register free: http://www.appliedclinicaltrialsonline.com/act_w/success
Latest:
Clinical Trials in Kazakhstan: Open For BusinessThis brief overview of Kazakhstan presented by Vlad Bogin will help you get acquainted with this emerging clinical trial location.
Latest:
Interexpert Agreement on Adverse Events’ EvaluationStudy measures the differing judgment levels between clinical investigators and drug safety experts.
Latest:
Interexpert Agreement on Adverse Events’ EvaluationStudy measures the differing judgment levels between clinical investigators and drug safety experts.
Latest:
Interexpert Agreement on Adverse Events’ EvaluationStudy measures the differing judgment levels between clinical investigators and drug safety experts.
Latest:
Interexpert Agreement on Adverse Events’ EvaluationStudy measures the differing judgment levels between clinical investigators and drug safety experts.
Latest:
Leverage Site-Owned Tech to Improve Trial RetentionMajor Depressive Disorder patients display a reduced ability to feel pleasant experiences known as Anhedonia. Such a feature provides difficulties when treating depression and engaging patients during clinical trials.
Latest:
Orphan Drugs: Market Overview and Country-Specific AnalysisOrphan medicines have become a formidable R&D segment with robust growth that is expected to continue. Expansion is needed to cope with the issues of development and patient recruitment. An understanding of regulations, therefore, is critical.
Latest:
New Diagnostic Criteria Narrows the Definition of Parkinson's DiseaseThe Movement Disorders Society has recently published Clinical Diagnostic Criteria for Parkinson’s disease. These new guidelines allow for the diagnosis of clinically established and clinical probable Parkinson’s disease, which will help reduce errors in clinical trials.
Latest:
Tips to Get to (and through) FDA Approvals FasterWhile thousands of hours are spent in the hopes of finding more effective treatments, many of them are rejected due to administrative errors. These three tips can help reduce the frequency of common administrative mistakes during clinical trials.
